Fennec Pharmaceuticals Inc. (FENC)
NCM · Common · CUSIP 00686R200
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for FENC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
00686R200 (prev. 00686R101 )
Market Cap
Small Cap
IPO
6/22/2006 · $.74/share
Previous Symbol
ADHXF (changed 9/3/2014)
Previous Name
Adherex Technologies, Inc.
Business: Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of (a unique formulation of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.

Company Contact

CEO
Rostislav Raykov
CFO
Robert Andrade
Headquarters
68 TW Alexander Drive, Research Triangle Park, NC 27709
Phone
919-636-4530
Fax
919-890-0490
Investor Relations
Robert Andrade · 919-636-5299
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »